The Nature of Regulatory Autoantibody Changes Among Pregnant Women with Intrauterine Growth Restriction

Anenzyme-linked immunosorbent assay known as ELI-TEST was applied in 388 pregnant women in the gestational complication risk group who were 11– 4 weeks into pregnancy for the purpose of determining the serum content of Ig G class/that bind to double-stranded DNA, β2-glycoprotein I (β2 GP), total pho...

Full description

Saved in:
Bibliographic Details
Published in:BioNanoScience 2017-06, Vol.7 (2), p.373-375
Main Authors: Zamaleeva, R. S., Cherepanova, N. A., Frizina, A. V., Chistiakova, N. Y.
Format: Article
Language:English
Subjects:
Antineutrophil cytoplasmic antibodies
Autoantibodies
Biological and Medical Physics
Biomaterials
Biophysics
Circuits and Systems
Collagen
Deoxyribonucleic acid
DNA
Engineering
Glycoprotein I
Glycoproteins
Health risk assessment
Immunoglobulins
Insulin
Nanotechnology
Pathogenesis
Phospholipids
Pregnancy
Prenatal development
Risk groups
Vascular diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anenzyme-linked immunosorbent assay known as ELI-TEST was applied in 388 pregnant women in the gestational complication risk group who were 11– 4 weeks into pregnancy for the purpose of determining the serum content of Ig G class/that bind to double-stranded DNA, β2-glycoprotein I (β2 GP), total phospholipids (TFL), HCG vasculopathy markers (ANCA), collagen (Coll), PAPP-A, and insulin (Ins). After standardizing groups, 80 pregnant women with intrauterine growth restriction (IUGR) were selected for analysis. Characteristic changes in the levels of autoantibodies accompanying IUGR of varying severity were identified which not only gives a more accurate understanding of the pathogenesis of the disease but also enables one to define IUGR risk groups in the early stages of pregnancy.
ISSN:2191-1630
2191-1649
DOI:10.1007/s12668-016-0365-z